Adrian Lee, Director of the Institute for Precision Medicine at UPMC and Professor at the University of Pittsburgh, shared a post on LinkedIn:
“Today on the first day of SABCS 2025 was Special Session 2: Lobular Breast Cancer Updates — gathering researchers, clinicians and patient advocates to share the latest findings on diagnostics, emerging biomarkers, ILC-specific trials, and patient-centered perspectives. The session was chaired by Steffi Oesterreich and Marleen Kok.
This year at SABCS we are all encouraged to see a major signal — 112 talks and posters mentioning ‘lobular’, reflecting a growing global research focus on lobular breast cancer. The rising visibility at SABCS shows that the community is recognizing its unique biology, long-term behavior, and the need for tailored research and care.
Proud to be part of this movement toward greater awareness and innovation for lobular breast cancer.”
More posts from SABCS 2025.
